vs
Side-by-side financial comparison of HUTCHMED (China) Ltd (HCM) and WESBANCO INC (WSBC). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $257.2M, roughly 1.1× WESBANCO INC). WESBANCO INC runs the higher net margin — 34.5% vs 0.7%, a 33.7% gap on every dollar of revenue.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
WesBanco, Inc., is a bank holding company headquartered in Wheeling, West Virginia, United States. It has over 200 branches in West Virginia, Ohio, Western Pennsylvania, Kentucky, Maryland, and Southern Indiana.
HCM vs WSBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.8M | $257.2M |
| Net Profit | $2.0M | $88.6M |
| Gross Margin | 37.7% | — |
| Operating Margin | -13.2% | — |
| Net Margin | 0.7% | 34.5% |
| Revenue YoY | -16.5% | — |
| Net Profit YoY | -83.6% | 54.4% |
| EPS (diluted) | $0.00 | $0.88 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $257.2M | ||
| Q4 25 | $270.8M | $265.6M | ||
| Q3 25 | — | $261.6M | ||
| Q2 25 | $277.7M | $260.7M | ||
| Q1 25 | $324.5M | $193.2M | ||
| Q4 24 | — | $162.9M | ||
| Q3 24 | — | $150.8M | ||
| Q2 24 | $305.7M | $147.9M |
| Q1 26 | — | $88.6M | ||
| Q4 25 | $2.0M | $91.1M | ||
| Q3 25 | — | $83.6M | ||
| Q2 25 | $455.0M | $57.4M | ||
| Q1 25 | $11.9M | $-9.0M | ||
| Q4 24 | — | $49.6M | ||
| Q3 24 | — | $37.3M | ||
| Q2 24 | $25.8M | $28.9M |
| Q1 26 | — | — | ||
| Q4 25 | 37.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 48.0% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 41.1% | — |
| Q1 26 | — | — | ||
| Q4 25 | -13.2% | 43.2% | ||
| Q3 25 | — | 39.5% | ||
| Q2 25 | -1.3% | 27.2% | ||
| Q1 25 | -5.0% | -5.0% | ||
| Q4 24 | — | 38.0% | ||
| Q3 24 | — | 29.7% | ||
| Q2 24 | -9.0% | 23.7% |
| Q1 26 | — | 34.5% | ||
| Q4 25 | 0.7% | 34.3% | ||
| Q3 25 | — | 31.9% | ||
| Q2 25 | 163.8% | 22.0% | ||
| Q1 25 | 3.7% | -4.7% | ||
| Q4 24 | — | 30.5% | ||
| Q3 24 | — | 24.7% | ||
| Q2 24 | 8.4% | 19.5% |
| Q1 26 | — | $0.88 | ||
| Q4 25 | $0.00 | $0.97 | ||
| Q3 25 | — | $0.84 | ||
| Q2 25 | $0.52 | $0.57 | ||
| Q1 25 | $0.01 | $-0.15 | ||
| Q4 24 | — | $0.72 | ||
| Q3 24 | — | $0.54 | ||
| Q2 24 | $0.03 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.4B | — |
| Total DebtLower is stronger | $93.2M | — |
| Stockholders' EquityBook value | $1.2B | $4.1B |
| Total Assets | $1.8B | $27.5B |
| Debt / EquityLower = less leverage | 0.08× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $1.4B | $956.1M | ||
| Q3 25 | — | $1.0B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $836.1M | $1.1B | ||
| Q4 24 | — | $568.1M | ||
| Q3 24 | — | $620.9M | ||
| Q2 24 | $802.5M | $486.8M |
| Q1 26 | — | — | ||
| Q4 25 | $93.2M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $93.4M | — | ||
| Q1 25 | $82.8M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $82.1M | — |
| Q1 26 | — | $4.1B | ||
| Q4 25 | $1.2B | $4.0B | ||
| Q3 25 | — | $4.1B | ||
| Q2 25 | $1.2B | $3.8B | ||
| Q1 25 | $759.9M | $3.8B | ||
| Q4 24 | — | $2.8B | ||
| Q3 24 | — | $2.8B | ||
| Q2 24 | $740.1M | $2.5B |
| Q1 26 | — | $27.5B | ||
| Q4 25 | $1.8B | $27.7B | ||
| Q3 25 | — | $27.5B | ||
| Q2 25 | $1.8B | $27.6B | ||
| Q1 25 | $1.3B | $27.4B | ||
| Q4 24 | — | $18.7B | ||
| Q3 24 | — | $18.5B | ||
| Q2 24 | $1.3B | $18.1B |
| Q1 26 | — | — | ||
| Q4 25 | 0.08× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.08× | — | ||
| Q1 25 | 0.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.11× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.2M | — |
| Free Cash FlowOCF − Capex | $3.4M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 1.8% | — |
| Cash ConversionOCF / Net Profit | 4.21× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-96.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.2M | $290.4M | ||
| Q3 25 | — | $116.9M | ||
| Q2 25 | $-72.9M | $105.0M | ||
| Q1 25 | $40.3M | $-26.4M | ||
| Q4 24 | — | $211.0M | ||
| Q3 24 | — | $60.7M | ||
| Q2 24 | $-39.8M | $18.2M |
| Q1 26 | — | — | ||
| Q4 25 | $3.4M | $280.0M | ||
| Q3 25 | — | $114.9M | ||
| Q2 25 | $-82.2M | $98.3M | ||
| Q1 25 | $32.5M | $-30.7M | ||
| Q4 24 | — | $200.7M | ||
| Q3 24 | — | $56.9M | ||
| Q2 24 | $-49.9M | $17.3M |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 105.4% | ||
| Q3 25 | — | 43.9% | ||
| Q2 25 | -29.6% | 37.7% | ||
| Q1 25 | 10.0% | -15.9% | ||
| Q4 24 | — | 123.2% | ||
| Q3 24 | — | 37.7% | ||
| Q2 24 | -16.3% | 11.7% |
| Q1 26 | — | — | ||
| Q4 25 | 1.8% | 3.9% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | 3.3% | 2.6% | ||
| Q1 25 | 2.4% | 2.2% | ||
| Q4 24 | — | 6.3% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | 3.3% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | 4.21× | 3.19× | ||
| Q3 25 | — | 1.40× | ||
| Q2 25 | -0.16× | 1.83× | ||
| Q1 25 | 3.38× | — | ||
| Q4 24 | — | 4.25× | ||
| Q3 24 | — | 1.63× | ||
| Q2 24 | -1.54× | 0.63× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HCM
Segment breakdown not available.
WSBC
| Net Interest Income | $215.4M | 84% |
| Noninterest Income | $41.8M | 16% |
